Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
Auteurs principaux: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Oxford University Press
2018
|
Documents similaires
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
par: Wattanakul, T, et autres
Publié: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
par: Thanaporn Wattanakul, et autres
Publié: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
par: Chotsiri, P, et autres
Publié: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
par: Pukrittayakamee, S, et autres
Publié: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
par: Saito, M, et autres
Publié: (2018)